09Oct/13

U of S labs look at producing cancer fighting antibodies – News Talk 650 CKOM

Antibodies

StarPhoenix

U of S labs look at producing cancer fighting antibodies
News Talk 650 CKOM
A lab at the University of Saskatchewan is using their patented technology to generate therapeutic-grade antibodies to treat breast cancer and leukemia. An investment of $1.7 million from the federal government’s Western Economic Diversification (WED …
U of S team on the brink of new cancer treatmentStarPhoenix
Harper Government and Government of Saskatchewan Invest in New Cancer …Marketwired (press release)
University of Saskatchewan gets $1.7M for cancer researchMetroNews Canada

all 6 news articles »
08Oct/13

Cellmid awarded key European midkine antibodies patent, covers cancer and … – Proactive Investors Australia

Antibodies

Proactive Investors Australia

Cellmid awarded key European midkine antibodies patent, covers cancer and …
Proactive Investors Australia
Maria Halasz, Cellmid’s chief executive officer, commented: “Having patents granted in Europe for our MK antibodies across such a wide array of diseases is a tremendous commercial outcome for Cellmid. “This patent gives Cellmid very clear exclusive …
08Oct/13

CELLMID LIMITED : Key European Patent for Anti-Midkine Antibodies Granted – 4-traders (press release)

Antibodies

Proactive Investors Australia

CELLMID LIMITED : Key European Patent for Anti-Midkine Antibodies Granted
4-traders (press release)
The granted claims cover Cellmid’s cancer program for antibodies and antibody fragments which bind to the important functional C-domain of growth factor midkine (MK). In particular, antibodies of any kind that bind to key MK C-domain epitopes are covered.
Cellmid awarded key European midkine antibodies patent, covers cancer and …Proactive Investors Australia
Cellmid, Key European Patent for Anti-Midkine Antibodies GrantedFinance News Network

all 3 news articles »